Cell-free fetal nucleic acids as prenatal biomarkers

Bibliography

• Bossuyt PM, Reitsma JB, Bruns DE, Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003;49(1):1-6
   PubMed Web of Science ®Google Scholar
• Hung EC, Chiu RW, Lo YM. Detection of circulating fetal nucleic acids: a review of methods and applications. J Clin Pathol 2009;5(4):308-13
   Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350(9076):485-7
   PubMed Web of Science ®Google Scholar
• Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46(11):1832-4
   PubMed Web of Science ®Google Scholar
• Alberry M, Maddocks D, Jones M, Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27(5):415-18
   PubMed Web of Science ®Google Scholar
• Chim SS, Shing TK, Hung EC, Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008;54(3):482-90
   PubMed Web of Science ®Google Scholar
• Chim SS, Tong YK, Chiu RW, Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005;102(41):14753-8
   PubMed Web of Science ®Google Scholar
• Flori E, Doray B, Gautier E, Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod 2004;19(3):723-4
   PubMed Web of Science ®Google Scholar
• Masuzaki H, Miura K, Yoshiura KI, Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 2004;41(4):289-92
   PubMed Web of Science ®Google Scholar
• Ng EK, Tsui NB, Lau TK, mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003;100(8):4748-53
   PubMed Web of Science ®Google Scholar
• Sikora A, Zimmermann BG, Rusterholz C, Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem 2010;56(1):136-8
   PubMed Web of Science ®Google Scholar
• Chan KC, Ding C, Gerovassili A, Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52(12):2211-18
   PubMed Web of Science ®Google Scholar
• Tsui DW, Chan KC, Chim SS, Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 2007;27(13):1212-18
   PubMed Web of Science ®Google Scholar
• Zejskova L, Jancuskova T, Kotlabova K, Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma – Next step toward reliable non-invasive prenatal diagnostics. Exp Mol Pathol 2010;89(3):241-7
   Google Scholar
• Farina A, Sekizawa A, Rizzo N, Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. Prenat Diagn 2004;24(4):293-7
   PubMed Web of Science ®Google Scholar
• Lau TW, Leung TN, Chan LY, Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002;48(12):2141-6
   PubMed Web of Science ®Google Scholar
• Levine RJ, Qian C, Leshane ES, Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190(3):707-13
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung TN, Tein MS, Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45(2):184-8
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Jimbo M, Saito H, Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003;188(2):480-4
   PubMed Web of Science ®Google Scholar
• Shimada K, Murakami K, Shozu M, Sex-determining region Y levels in maternal plasma: Evaluation in abnormal pregnancy. J Obstet Gynaecol Res 2004;30(2):148-54
   PubMed Web of Science ®Google Scholar
• Smid M, Galbiati S, Lojacono A, Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn 2006;26(9):785-90
   PubMed Web of Science ®Google Scholar
• Smid M, Vassallo A, Lagona F, Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann N Y Acad Sci 2001;945:132-7
   PubMed Web of Science ®Google Scholar
• Swinkels DW, de Kok JB, Hendriks JC, Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002;48(4):650-3
   PubMed Web of Science ®Google Scholar
• Zhong XY, Gebhardt S, Hillermann R, Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem 2005;51(9):1730-3
   PubMed Web of Science ®Google Scholar
• Zhong XY, Laivuori H, Livingston JC, Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184(3):414-19
   PubMed Web of Science ®Google Scholar
• Alberry MS, Maddocks DG, Hadi MA, Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol 2009;200(1): 98 e1-6
   PubMed Web of Science ®Google Scholar
• Crowley A, Martin C, Fitzpatrick P, Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia. Prenat Diagn 2007;27(2):174-9
   PubMed Web of Science ®Google Scholar
• Farina A, Sekizawa A, Sugito Y, Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004;24(2):83-6
   PubMed Web of Science ®Google Scholar
• Leung TN, Zhang J, Lau TK, Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001;47(1):137-9
   PubMed Web of Science ®Google Scholar
• Sifakis S, Zaravinos A, Maiz N, First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 2009;201(5):472 e1-7
   Google Scholar
• Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002;21(1):77-83
   PubMed Web of Science ®Google Scholar
• Al Nakib M, Desbriere R, Bonello N, Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther 2009;26(1):24-8
   PubMed Web of Science ®Google Scholar
• Caramelli E, Rizzo N, Concu M, Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction – a pilot study. Prenat Diagn 2003;23(5):367-71
   PubMed Web of Science ®Google Scholar
• Farina A, LeShane ES, Romero R, High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193(2):421-5
   PubMed Web of Science ®Google Scholar
• Leung TN, Zhang J, Lau TK, Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352(9144):1904-5
   PubMed Web of Science ®Google Scholar
• Zhong XY, Holzgreve W, Hahn S. Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts. Mol Hum Reprod 2002;8(9):864-70
   PubMed Web of Science ®Google Scholar
• Lo YM, Lau TK, Zhang J, Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999;45(10):1747-51
   PubMed Web of Science ®Google Scholar
• Zhong XY, Burk MR, Troeger C, Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 2000;20(10):795-8
   PubMed Web of Science ®Google Scholar
• Huppertz B, Kadyrov M, Kingdom JC. Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 2006;195(1):29-39
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169(2):400-4
   PubMed Web of Science ®Google Scholar
• Avent ND, Madgett TE, Maddocks DG, Soothill PW. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications. Curr Opin Obstet Gynecol 2009;21(2):175-9
   PubMed Web of Science ®Google Scholar
• Hahn S, Chitty LS. Noninvasive prenatal diagnosis: current practice and future perspectives. Curr Opin Obstet Gynecol 2008;20(2):146-51
   PubMed Web of Science ®Google Scholar
• Saito H, Sekizawa A, Morimoto T, Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000;356(9236):1170
   PubMed Web of Science ®Google Scholar
• Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46(2):301-2
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lau TK, Leung TN, Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360(9338):998-1000
   PubMed Web of Science ®Google Scholar
• Galbiati S, Foglieni B, Travi M, Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of beta-thalassemia. Haematologica 2008;93(4):610-14
   PubMed Web of Science ®Google Scholar
• Lazaros L, Hatzi E, Bouba I, Non-invasive first-trimester detection of paternal beta-globin gene mutations and polymorphisms as predictors of thalassemia risk at chorionic villous sampling. Eur J Obstet Gynecol Reprod Biol 2008;140(1):17-20
   PubMed Web of Science ®Google Scholar
• Li Y, Di Naro E, Vitucci A, Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry. Fetal Diagn Ther 2009;25(2):246-9
   PubMed Web of Science ®Google Scholar
• Li Y, Di Naro E, Vitucci A, Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293(7):843-9
   PubMed Web of Science ®Google Scholar
• Ding C, Chiu RW, Lau TK, MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004;101(29):10762-7
   PubMed Web of Science ®Google Scholar
• Ding C. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma. Methods Mol Biol 2008;444:253-67
   PubMedGoogle Scholar
• Li Y, Zimmermann B, Rusterholz C, Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004;50(6):1002-11
   PubMed Web of Science ®Google Scholar
• Tsang JC, Charoenkwan P, Chow KC, Mass spectrometry-based detection of hemoglobin E mutation by allele-specific base extension reaction. Clin Chem 2007;53(12):2205-9
   PubMed Web of Science ®Google Scholar
• Li Y, Page-Christiaens GC, Gille JJ, Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007;27(1):11-17
   PubMed Web of Science ®Google Scholar
• Bruno F, Damin F, Causarano V, High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma. Clin Chem Lab Med 2009;47(7):818-23
   PubMed Web of Science ®Google Scholar
• Wataganara T, Peter I, Messerlian GM, Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol 2004;104(3):545-50
   PubMed Web of Science ®Google Scholar
• Gerovassili A, Nicolaides KH, Thein SL, Rees DC. Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation. Br J Haematol 2006;135(5):738-41
   PubMed Web of Science ®Google Scholar
• Gerovassili A, Garner C, Nicolaides KH, Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn 2007;27(2):104-10
   PubMed Web of Science ®Google Scholar
• Hromadnikova I, Houbova B, Hridelova D, Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies. BMC Pregnancy Childbirth 2002;2(1):4
   PubMedGoogle Scholar
• Ohashi Y, Miharu N, Honda H, Quantitation of fetal DNA in maternal serum in normal and aneuploid prenancies. Hum Genet 2001;108(2):123-7
   PubMed Web of Science ®Google Scholar
• Banzola I, Rusterholz C, Zannoni L, PLAC4 and beta-HCG mRNA levels are not altered in the maternal circulation of pregnancies with trisomy 21. Prenat Diagn 2008;28(13):1262-7
   PubMed Web of Science ®Google Scholar
• Brizot ML, Jauniaux E, McKie AT, Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome. Hum Reprod 1995;10(9):2506-9
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Hochberg A, deGroot N, Weinstein D. High maternal serum chorionic gonadotropin level in Downs' syndrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts. J Clin Endocrinol Metab 1995;80(12):3528-31
   PubMed Web of Science ®Google Scholar
• Massin N, Frendo JL, Guibourdenche J, Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome. Placenta 2001;22(Suppl A):S93-7
   PubMedGoogle Scholar
• Lo YM, Tsui NB, Chiu RW, Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13(2):218-23
   PubMed Web of Science ®Google Scholar
• Chiu RW, Chan KC, Gao Y, Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105(51):20458-63
   PubMed Web of Science ®Google Scholar
• Fan HC, Blumenfeld YJ, Chitkara U, Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105(42):16266-71
   PubMed Web of Science ®Google Scholar
• Lo YM, Chan KC, Sun H, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2(61): 61ra91
   Web of Science ®Google Scholar
• Finning K, Martin P, Summers J, Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336(7648):816-18
   PubMed Web of Science ®Google Scholar
• Geifman-Holtzman O, Grotegut CA, Gaughan JP, Noninvasive fetal RhCE genotyping from maternal blood. BJOG 2009;116(2):144-51
   PubMed Web of Science ®Google Scholar
• Li Y, Finning K, Daniels G, Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat Diagn 2008;28(3):203-8
   PubMed Web of Science ®Google Scholar
• Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999;340(16):1228-33
   PubMed Web of Science ®Google Scholar
• Ward HJ, MacKenzie JM, Llewelyn CA, Variant Creutzfeldt-Jakob disease and exposure to fractionated plasma products. Vox Sang 2009;97(3):207-10
   PubMed Web of Science ®Google Scholar
• Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood – a meta-analysis. Am J Obstet Gynecol 2006;195(4):1163-73
   PubMed Web of Science ®Google Scholar
• Freeman K, Szczepura A, Osipenko L. Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. Eur J Obstet Gynecol Reprod Biol 2009;142(2):91-8
   PubMed Web of Science ®Google Scholar
• Singleton BK, Green CA, Avent ND, The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 2000;95(1):12-18
   PubMed Web of Science ®Google Scholar
• Galbiati S, Causarano V, Pinzani P, Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy. Clin Chem Lab Med 2010;48(6):791-4
   PubMed Web of Science ®Google Scholar
• Hromadnikova I, Zejskova L, Kotlabova K, Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences – evaluation of diagnostic possibilities for predicting placental insufficiency. DNA Cell Biol 2010;29(6):295-301
   PubMed Web of Science ®Google Scholar
• Zhao F, Wang J, Liu R, Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma. Prenat Diagn 2010;30(8):778-82
   PubMed Web of Science ®Google Scholar
• Purwosunu Y, Sekizawa A, Okazaki S, Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma. Am J Obstet Gynecol 2009;200(4): 386 e1-7
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116(2 Pt 1):402-14
   PubMed Web of Science ®Google Scholar
• Illanes S, Parra M, Serra R, Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009;29(12):1118-22
   PubMed Web of Science ®Google Scholar
• Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 2005;26(7):515-26
   PubMed Web of Science ®Google Scholar
• Hoesli I, Danek M, Lin D, Circulating erythroblasts in maternal blood are not elevated before onset of preterm labor. Obstet Gynecol 2002;100(5 Pt 1):992-6
   PubMed Web of Science ®Google Scholar
• Mazouni C, Gorincour G, Juhan V, Bretelle F. Placenta accreta: a review of current advances in prenatal diagnosis. Placenta 2007;28(7):599-603
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Jimbo M, Saito H, Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002;48(2):353-4
   PubMed Web of Science ®Google Scholar
• Jimbo M, Sekizawa A, Sugito Y, Placenta increta: postpartum monitoring of plasma cell-free fetal DNA. Clin Chem 2003;49(9):1540-1
   PubMed Web of Science ®Google Scholar
• Masuzaki H, Miura K, Yoshiura K, Placental mRNA in maternal plasma and its clinical application to the evaluation of placental status in a pregnant woman with placenta previa-percreta. Clin Chem 2005;51(5):923-5
   PubMed Web of Science ®Google Scholar
• Okuda T, Kinoshita Y, Tamura T, Quantitative analysis of cellular fetal hemoglobin gamma chain messenger RNA (HbF-gamma mRNA) in maternal peripheral blood. Prenat Diagn 2004;24(11):881-6
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Jani J, Lewi L, Circulating cell-free fetal messenger RNA levels after fetoscopic interventions of complicated pregnancies. Am J Obstet Gynecol 2006;195(1):230-5
   PubMed Web of Science ®Google Scholar
• Miura K, Miura S, Yamasaki K, Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn 2008;28(9):805-9
   PubMed Web of Science ®Google Scholar
• El Behery MM, Rasha LE, El Alfy Y. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynaecol Obstet 2010;109(1):30-3
   PubMed Web of Science ®Google Scholar